Bank of Montreal’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-17,382
| Closed | -$30.2K | – | 3880 |
|
|
2025
Q4 | $30.2K | Hold |
17,382
| – | – | ﹤0.01% | 3286 |
|
|
2025
Q3 | $40.7K | Sell |
17,382
-40,564
| -70% | -$77.7K | ﹤0.01% | 3164 |
|
|
2025
Q2 | $118K | Buy |
57,946
+11,110
| +24% | +$21.3K | ﹤0.01% | 2943 |
|
|
2025
Q1 | $76.3K | Buy |
46,836
+23,341
| +99% | +$46.8K | ﹤0.01% | 2974 |
|
|
2024
Q4 | $43K | Buy |
+23,495
| New | +$104K | ﹤0.01% | 3141 |
|
|
2023
Q2 | – | Sell |
-1,287
| Closed | -$13K | – | 4135 |
|
|
2023
Q1 | $13K | Buy |
+1,287
| New | +$21.9K | ﹤0.01% | 3588 |
|
|
2022
Q2 | – | Sell |
-1,592
| Closed | -$70K | – | 4250 |
|
|
2022
Q1 | $70K | Buy |
1,592
+410
| +35% | +$18.5K | ﹤0.01% | 3730 |
|
|
2021
Q4 | $75K | Buy |
1,182
+350
| +42% | +$28K | ﹤0.01% | 3168 |
|
|
2021
Q3 | $80K | Buy |
+832
| New | +$83.5K | ﹤0.01% | 3488 |
|
|
2021
Q2 | – | Sell |
-9,942
| Closed | -$1.05M | – | 4263 |
|
|
2021
Q1 | $1.05M | Sell |
9,942
-2,096
| -17% | -$276K | ﹤0.01% | 2158 |
|
|
2020
Q4 | $1.31M | Sell |
12,038
-11,735
| -49% | -$1.56M | ﹤0.01% | 2062 |
|
|
2020
Q3 | $3.54M | Buy |
23,773
+21,784
| +1,095% | +$4.54M | ﹤0.01% | 1406 |
|
|
2020
Q2 | $556K | Sell |
1,989
-2,530
| -56% | -$406K | ﹤0.01% | 2214 |
|
|
2020
Q1 | $408K | Buy |
4,519
+3,099
| +218% | +$191K | ﹤0.01% | 2072 |
|
|
2019
Q4 | $57K | Buy |
1,420
+326
| +30% | +$9.81K | ﹤0.01% | 3785 |
|
|
2019
Q3 | $27K | Buy |
1,094
+460
| +73% | +$14K | ﹤0.01% | 3919 |
|
|
2019
Q2 | $22K | Buy |
634
+301
| +90% | +$12K | ﹤0.01% | 4120 |
|
|
2019
Q1 | $15K | Sell |
333
-96
| -22% | -$4.84K | ﹤0.01% | 3752 |
|
|
2018
Q4 | $21K | Buy |
429
+48
| +13% | +$2.92K | ﹤0.01% | 3625 |
|
|
2018
Q3 | $25K | Buy |
381
+165
| +76% | +$9.19K | ﹤0.01% | 3634 |
|
|
2018
Q2 | $10K | Sell |
216
-14,557
| -99% | -$803K | ﹤0.01% | 3953 |
|
|
2018
Q1 | $835K | Sell |
14,773
-2,903
| -16% | -$157K | ﹤0.01% | 2001 |
|
|
2017
Q4 | $876K | Buy |
17,676
+2,367
| +15% | +$147K | ﹤0.01% | 2025 |
|
|
2017
Q3 | $1.17M | Buy |
+15,309
| New | +$1.14M | ﹤0.01% | 1906 |
|
|
2017
Q1 | – | Sell |
-2,640
| Closed | -$224K | – | 4080 |
|
|
2016
Q4 | $224K | Sell |
2,640
-425
| -14% | -$38.4K | ﹤0.01% | 2444 |
|
|
2016
Q3 | $342K | Sell |
3,065
-3,438
| -53% | -$380K | ﹤0.01% | 2221 |
|
|
2016
Q2 | $721K | Buy |
6,503
+4,444
| +216% | +$540K | ﹤0.01% | 1979 |
|
|
2016
Q1 | $215K | Buy |
2,059
+728
| +55% | +$56.2K | ﹤0.01% | 2419 |
|
|
2015
Q4 | $108K | Buy |
1,331
+1,299
| +4,059% | +$103K | ﹤0.01% | 2746 |
|
|
2015
Q3 | $2K | Hold |
32
| – | – | ﹤0.01% | 3800 |
|
|
2015
Q2 | $3K | Hold |
32
| – | – | ﹤0.01% | 3692 |
|
|
2015
Q1 | $3K | Hold |
32
| – | – | ﹤0.01% | 3716 |
|
|
2014
Q4 | $3K | Buy |
+32
| New | +$3.91K | ﹤0.01% | 3778 |
|
|
2014
Q2 | – | Sell |
-177
| Closed | -$28K | – | 4743 |
|
|
2014
Q1 | $28K | Buy |
+177
| New | +$25.4K | ﹤0.01% | 3364 |
|
Other funds holding INO
VCM
BCM
ACM
EP
Bank of Montreal's INO Position: Q1 2026 in Review
Bank of Montreal sold out of Inovio Pharmaceuticals (INO) in Q1 2026, closing a stake of 17,382 shares — an estimated $30.2K sold.
Bank of Montreal first reported a position in INO in Q1 2014 and held it in 34 quarters. The position peaked at $3.54M in Q3 2020. 100 funds tracked by Wall St. Rank hold INO as of Q1 2026.
- Bank of Montreal reported no remaining Inovio Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Bank of Montreal sold 17,382 Inovio Pharmaceuticals shares in Q1 2026, an estimated $30.2K.
- Bank of Montreal first reported a position in Inovio Pharmaceuticals in Q1 2014 and held it in 34 quarters.
- Bank of Montreal's Inovio Pharmaceuticals position peaked at $3.54M in Q3 2020.
- 100 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2026.
Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.